These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 36611213)

  • 1. Continuity of care (COC) and amyloid-β PET scan: the CARE-IDEAS study.
    O'Brien EC; Ford CB; Sorenson C; Jutkowitz E; Shepherd-Banigan M; Van Houtven C
    Alzheimers Res Ther; 2023 Jan; 15(1):6. PubMed ID: 36611213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Amyloid Positron Emission Tomography With Subsequent Change in Clinical Management Among Medicare Beneficiaries With Mild Cognitive Impairment or Dementia.
    Rabinovici GD; Gatsonis C; Apgar C; Chaudhary K; Gareen I; Hanna L; Hendrix J; Hillner BE; Olson C; Lesman-Segev OH; Romanoff J; Siegel BA; Whitmer RA; Carrillo MC
    JAMA; 2019 Apr; 321(13):1286-1294. PubMed ID: 30938796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amyloid Positron Emission Tomography and Subsequent Health Care Use Among Medicare Beneficiaries With Mild Cognitive Impairment or Dementia.
    Rabinovici GD; Carrillo MC; Apgar C; Gareen IF; Gutman R; Hanna L; Hillner BE; March A; Romanoff J; Siegel BA; Smith K; Song Y; Weber C; Whitmer RA; Gatsonis C
    JAMA Neurol; 2023 Nov; 80(11):1166-1173. PubMed ID: 37812437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amyloid-β PET Scan Results Disclosure and Care-Partner Emotional Well-Being Over Time.
    Shepherd-Banigan ME; Ford CB; Smith VA; Belanger E; Wetle TT; Plassman BL; Burke JR; DePasquale N; O'Brien EC; Sorenson C; Van Houtven CH
    J Alzheimers Dis; 2022; 90(2):775-782. PubMed ID: 36189596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between results of an amyloid PET scan and healthcare utilization in individuals with cognitive impairment.
    Jutkowitz E; Shewmaker P; Ford CB; Smith VA; O'Brien E; Shepherd-Banigan M; Belanger E; Plassman BL; Burke JR; Van Houtven CH; Wetle T
    J Am Geriatr Soc; 2024 Mar; 72(3):707-717. PubMed ID: 38069618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated Amyloid-β PET Scan and Cognitive and Functional Decline in Mild Cognitive Impairment and Dementia of Uncertain Etiology.
    Plassman BL; Ford CB; Smith VA; DePasquale N; Burke JR; Korthauer L; Ott BR; Belanger E; Shepherd-Banigan ME; Couch E; Jutkowitz E; O'Brien EC; Sorenson C; Wetle TT; Van Houtven CH
    J Alzheimers Dis; 2024; 97(3):1161-1171. PubMed ID: 38306055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association Between Ambient Air Pollution and Amyloid Positron Emission Tomography Positivity in Older Adults With Cognitive Impairment.
    Iaccarino L; La Joie R; Lesman-Segev OH; Lee E; Hanna L; Allen IE; Hillner BE; Siegel BA; Whitmer RA; Carrillo MC; Gatsonis C; Rabinovici GD
    JAMA Neurol; 2021 Feb; 78(2):197-207. PubMed ID: 33252608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How Accurately Do Patients and Their Care Partners Report Results of Amyloid-β PET Scans for Alzheimer's Disease Assessment?
    James HJ; Van Houtven CH; Lippmann S; Burke JR; Shepherd-Banigan M; Belanger E; Wetle TF; Plassman BL
    J Alzheimers Dis; 2020; 74(2):625-636. PubMed ID: 32065790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of Amyloid Positron Emission Tomography With Changes in Diagnosis and Patient Treatment in an Unselected Memory Clinic Cohort: The ABIDE Project.
    de Wilde A; van der Flier WM; Pelkmans W; Bouwman F; Verwer J; Groot C; van Buchem MM; Zwan M; Ossenkoppele R; Yaqub M; Kunneman M; Smets EMA; Barkhof F; Lammertsma AA; Stephens A; van Lier E; Biessels GJ; van Berckel BN; Scheltens P
    JAMA Neurol; 2018 Sep; 75(9):1062-1070. PubMed ID: 29889941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Racial and Ethnic Differences in Amyloid PET Positivity in Individuals With Mild Cognitive Impairment or Dementia: A Secondary Analysis of the Imaging Dementia-Evidence for Amyloid Scanning (IDEAS) Cohort Study.
    Wilkins CH; Windon CC; Dilworth-Anderson P; Romanoff J; Gatsonis C; Hanna L; Apgar C; Gareen IF; Hill CV; Hillner BE; March A; Siegel BA; Whitmer RA; Carrillo MC; Rabinovici GD
    JAMA Neurol; 2022 Oct; 79(11):1139-47. PubMed ID: 36190710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beta amyloid PET scans for dementia diagnoses: Practice and research implications from CARE-IDEAS.
    Wetle TT; Van Houtven CH; Shepherd-Banigan ME; Belanger E; Couch E; Sorenson C; Gadbois EA; Burke JR; Jutkowitz E; O'Brien EC; Plassman BL
    J Am Geriatr Soc; 2024 Oct; 72(10):2981-2988. PubMed ID: 38798126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence Estimates of Amyloid Abnormality Across the Alzheimer Disease Clinical Spectrum.
    Jansen WJ; Janssen O; Tijms BM; Vos SJB; Ossenkoppele R; Visser PJ; ; Aarsland D; Alcolea D; Altomare D; von Arnim C; Baiardi S; Baldeiras I; Barthel H; Bateman RJ; Van Berckel B; Binette AP; Blennow K; Boada M; Boecker H; Bottlaender M; den Braber A; Brooks DJ; Van Buchem MA; Camus V; Carill JM; Cerman J; Chen K; Chételat G; Chipi E; Cohen AD; Daniels A; Delarue M; Didic M; Drzezga A; Dubois B; Eckerström M; Ekblad LL; Engelborghs S; Epelbaum S; Fagan AM; Fan Y; Fladby T; Fleisher AS; Van der Flier WM; Förster S; Fortea J; Frederiksen KS; Freund-Levi Y; Frings L; Frisoni GB; Fröhlich L; Gabryelewicz T; Gertz HJ; Gill KD; Gkatzima O; Gómez-Tortosa E; Grimmer T; Guedj E; Habeck CG; Hampel H; Handels R; Hansson O; Hausner L; Hellwig S; Heneka MT; Herukka SK; Hildebrandt H; Hodges J; Hort J; Huang CC; Iriondo AJ; Itoh Y; Ivanoiu A; Jagust WJ; Jessen F; Johannsen P; Johnson KA; Kandimalla R; Kapaki EN; Kern S; Kilander L; Klimkowicz-Mrowiec A; Klunk WE; Koglin N; Kornhuber J; Kramberger MG; Kuo HC; Van Laere K; Landau SM; Landeau B; Lee DY; de Leon M; Leyton CE; Lin KJ; Lleó A; Löwenmark M; Madsen K; Maier W; Marcusson J; Marquié M; Martinez-Lage P; Maserejian N; Mattsson N; de Mendonça A; Meyer PT; Miller BL; Minatani S; Mintun MA; Mok VCT; Molinuevo JL; Morbelli SD; Morris JC; Mroczko B; Na DL; Newberg A; Nobili F; Nordberg A; Olde Rikkert MGM; de Oliveira CR; Olivieri P; Orellana A; Paraskevas G; Parchi P; Pardini M; Parnetti L; Peters O; Poirier J; Popp J; Prabhakar S; Rabinovici GD; Ramakers IH; Rami L; Reiman EM; Rinne JO; Rodrigue KM; Rodríguez-Rodriguez E; Roe CM; Rosa-Neto P; Rosen HJ; Rot U; Rowe CC; Rüther E; Ruiz A; Sabri O; Sakhardande J; Sánchez-Juan P; Sando SB; Santana I; Sarazin M; Scheltens P; Schröder J; Selnes P; Seo SW; Silva D; Skoog I; Snyder PJ; Soininen H; Sollberger M; Sperling RA; Spiru L; Stern Y; Stomrud E; Takeda A; Teichmann M; Teunissen CE; Thompson LI; Tomassen J; Tsolaki M; Vandenberghe R; Verbeek MM; Verhey FRJ; Villemagne V; Villeneuve S; Vogelgsang J; Waldemar G; Wallin A; Wallin ÅK; Wiltfang J; Wolk DA; Yen TC; Zboch M; Zetterberg H
    JAMA Neurol; 2022 Mar; 79(3):228-243. PubMed ID: 35099509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Continuity of Care and Health Care Utilization in Older Adults With Dementia in Fee-for-Service Medicare.
    Amjad H; Carmichael D; Austin AM; Chang CH; Bynum JP
    JAMA Intern Med; 2016 Sep; 176(9):1371-8. PubMed ID: 27454945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. "I know that my role is going to change": a mixed-methods study of the relationship between amyloid-β PET scan results and caregiver burden.
    Couch E; Belanger E; Gadbois EA; DePasquale N; Zhang W; Wetle T
    Aging Clin Exp Res; 2023 Feb; 35(2):387-397. PubMed ID: 36484946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Continuity of care and receipt of aggressive end of life care among women dying of ovarian cancer.
    Mullins MA; Ruterbusch JJ; Clarke P; Uppal S; Cote ML; Wallner LP
    Gynecol Oncol; 2021 Jul; 162(1):148-153. PubMed ID: 33931242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Added value and limitations of amyloid-PET imaging: review and analysis of selected cases of mild cognitive impairment and dementia.
    Weidman DA; Zamrini E; Sabbagh MN; Jacobson S; Burke A; Belden C; Powell J; Bhalla N; Roontiva A; Kuang X; Luo J; Chen K; Riggs G; Burke W
    Neurocase; 2017 Feb; 23(1):41-51. PubMed ID: 28376695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Can Continuity of Care Reduce Hospitalization Among Community-dwelling Older Adult Veterans Living With Dementia?
    Lei L; Cai S; Conwell Y; Fortinsky RH; Intrator O
    Med Care; 2020 Nov; 58(11):988-995. PubMed ID: 32925470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Physician-Level Continuity of Care and Patient Outcomes in All-Payer Claims Database.
    Dai M; Morgan ZJ; Russel K; Bortz BA; Peterson LE; Bazemore AW
    J Am Board Fam Med; 2024 Jan; 36(6):976-985. PubMed ID: 38171580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Value of Knowing: Health-Related Behavior Changes following Amyloid PET Results Disclosure in Mild Cognitive Impairment.
    Wang Y; Ren D; Roberts JS; Tamres LK; Lingler JH
    J Prev Alzheimers Dis; 2024; 11(4):958-965. PubMed ID: 39044506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of Amyloid and Tau PET on Changes in Diagnosis and Patient Management.
    Shimohama S; Tezuka T; Takahata K; Bun S; Tabuchi H; Seki M; Momota Y; Suzuki N; Morimoto A; Iwabuchi Y; Kubota M; Yamamoto Y; Sano Y; Shikimoto R; Funaki K; Mimura Y; Nishimoto Y; Ueda R; Jinzaki M; Nakahara J; Mimura M; Ito D
    Neurology; 2023 Jan; 100(3):e264-e274. PubMed ID: 36175151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.